DGAT1 and obesity due to melanocortin 4 receptor deficiency: Given the DGAT1 enzymes represent interesting therapeutic targets in obesity [5–7], insulin resistance [10, 31], and in hepatitis C virus infection [32], it is important that DGAT1 structure-activity relationships are characterized, especially in the absence of any crystal structure of this enzyme or a close homologue.